Now Reading: Manipal Hospitals revenue jumps 38% to Rs 3,091 crore in Q1
-
01
Manipal Hospitals revenue jumps 38% to Rs 3,091 crore in Q1
Manipal Hospitals reported a 38.1% rise in revenue to Rs 3,091 crore for the quarter ended June 2025, its first as a listed company. EBITDA grew 26.4% to Rs 749 crore, but…
Manipal Hospitals reported a 38.1% rise in revenue to Rs 3,091 crore for the quarter ended June 2025, its first as a listed company. EBITDA grew 26.4% to Rs 749 crore, but profit after tax fell 4.2% to Rs 243 crore due to an Rs 89 crore interest charge on non-convertible debentures raised for the Sahyadri Hospitals acquisition. Adjusted for that cost, PAT rose 30.9%.
The hospital chain saw inpatient volumes surge 38.8% and outpatient volumes grow 26%, with occupancy improving to 65%. Revenue from high-acuity CONGO-R specialties rose 45%, led by oncology (up 62%) and orthopedics (up 49%). Average revenue per occupied bed excluding Sahyadri stood at Rs 77,200 per day, up 8.7%.
Sahyadri Hospitals recorded 12.8% revenue growth and 18.7% EBITDA growth in the quarter. CEO Dilip Jose said the results reflect the strength of the pan-India network and sustained demand for complex care.
Indian Opinion Analysis
The earnings release comes as Manipal Hospitals transitions to life as a publicly listed company: it debuted on the stock exchanges in May 2025, making this its first quarterly report as a listed entity. The Sahyadri Hospitals acquisition cost that dented PAT is a one-time financing charge, so the underlying profitability is stronger than the headline figure suggests. Investors watching the stock will focus on whether occupancy and CONGO-R volumes sustain their growth trajectory. The next key signal will be the hospital chain's capital expenditure plans and any further acquisition announcements.
Source: health.economictimes.indiatimes.com
This story was synthesised by AI from the source linked above.
